Literature DB >> 12741503

Inverse planning for intensity-modulated arc therapy using direct aperture optimization.

M A Earl1, D M Shepard, S Naqvi, X A Li, C X Yu.   

Abstract

Intensity-modulated arc therapy (IMAT) is a radiation therapy delivery technique that combines gantry rotation with dynamic multi-leaf collimation (MLC). With IMAT, the benefits of rotational IMRT can be realized using a conventional linear accelerator and a conventional MLC. Thus far, the advantages of IMAT have gone largely unrealized due to the lack of robust automated planning tools capable of producing efficient IMAT treatment plans. This work describes an inverse treatment planning algorithm, called 'direct aperture optimization' (DAO) that can be used to generate inverse treatment plans for IMAT. In contrast to traditional inverse planning techniques where the relative weights of a series of pencil beams are optimized, DAO optimizes the leaf positions and weights of the apertures in the plan. This technique allows any delivery constraints to be enforced during the optimization, eliminating the need for a leaf-sequencing step. It is this feature that enables DAO to easily create inverse plans for IMAT. To illustrate the feasibility of DAO applied to IMAT, several cases are presented, including a cylindrical phantom, a head and neck patient and a prostate patient.

Entities:  

Mesh:

Year:  2003        PMID: 12741503     DOI: 10.1088/0031-9155/48/8/309

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  26 in total

1.  Dose correction strategy for the optimization of volumetric modulated arc therapy.

Authors:  Pengpeng Zhang; Jie Yang; Margie Hunt; Gig Mageras
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

2.  Quality Control of Portal Imaging with PTW EPID QC PHANTOM.

Authors:  Csilla Pesznyák; Gábor Fekete; Arpád Mózes; Balázs Kiss; Réka Király; István Polgár; Pál Zaránd; Arpád Mayer
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

3.  Four-dimensional inverse treatment planning with inclusion of implanted fiducials in IMRT segmented fields.

Authors:  Yunzhi Ma; Louis Lee; O Keshet; Paul Keall; Lei Xing
Journal:  Med Phys       Date:  2009-06       Impact factor: 4.071

4.  Penalization of aperture complexity in inversely planned volumetric modulated arc therapy.

Authors:  Kelly C Younge; Martha M Matuszak; Jean M Moran; Daniel L McShan; Benedick A Fraass; Donald A Roberts
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

5.  Deterministic direct aperture optimization using multiphase piecewise constant segmentation.

Authors:  Dan Nguyen; Daniel O'Connor; Dan Ruan; Ke Sheng
Journal:  Med Phys       Date:  2017-09-22       Impact factor: 4.071

6.  Use of plan quality degradation to evaluate tradeoffs in delivery efficiency and clinical plan metrics arising from IMRT optimizer and sequencer compromises.

Authors:  Joel R Wilkie; Martha M Matuszak; Mary Feng; Jean M Moran; Benedick A Fraass
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

7.  Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses.

Authors:  E K Uzel; S Karaçam; O Eliçin; O Uzel
Journal:  Strahlenther Onkol       Date:  2013-06-09       Impact factor: 3.621

8.  Advantage of 3D volumetric dosemeter in delivery quality assurance of dynamic arc therapy: comparison of pencil beam and Monte Carlo calculations.

Authors:  H-J Shin; J H Song; J-Y Jung; Y-K Kwak; C S Kay; Y-N Kang; B O Choi; H S Jang; S H Son
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

9.  Remarks on reporting and recording consistent with the ICRU reference dose.

Authors:  Klaus Bratengeier; Markus Oechsner; Mark Gainey; Michael Flentje
Journal:  Radiat Oncol       Date:  2009-10-14       Impact factor: 3.481

10.  A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT).

Authors:  Florian Stieler; Dirk Wolff; Frank Lohr; Volker Steil; Yasser Abo-Madyan; Friedlieb Lorenz; Frederik Wenz; Sabine Mai
Journal:  Radiat Oncol       Date:  2009-10-25       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.